PERIPHERAL CHEMO-CYTOKINE PROFILES IN ALZHEIMER’S AND PARKINSON’S DISEASES

Por Reale, M., Greig, N.H., Kamal, M.A.
Publicado em 2009

Enhanced survival of dopaminergic neuronal transplants in hemi-Parkinsonian rats by the p53 inactivator PFT-α

Por Chou, J., Greig, N.H., Reiner, D., Hoffer, B.J., Wang, Y
Publicado em 2011

Relationship Between Inflammatory Mediators, Aβ Levels and ApoE Genotype in Alzheimer Disease

Por Reale, M., Kamal, M.A., Velluto, L., Gambi, D., Di Nicola, M., Greig, N.H.
Publicado no Curr Alzheimer Res (2012)

Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats.

Por Wang, Y, Perfetti, R, Greig, N H, Holloway, H W, DeOre, K A, Montrose-Rafizadeh, C, Elahi, D, Egan, J M
Publicado em 1997

Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice

Por Tweedie, D., Rachmany, L., Rubovitch, V., Lehrmann, E., Zhang, Y., Becker, K.G., Perez, E., Miller, J., Hoffer, B.J., Greig, N.H., Pick, C.G.
Publicado em 2012

The effects of age and LPS-mediated peripheral inflammation on numbers of central catecholaminergic neurons

Por Mouton, P.R., Kelley-Bell, B., Tweedie, D., Spangler, E.L, Perez, E., Carlson, O.D., Short, R.G., deCabo, R., Chang, J., Ingram, D.K., Li, Y., Greig, N.H.
Publicado em 2010